Anti-5HT3C/ HTR3C monoclonal antibody

Anti-5HT3C/ HTR3C antibody for FACS & in-vivo assay

Target products collectionGo to HTR3C/HTR3C products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0592-Ab-1/ GM-Tg-hg-MP0592-Ab-2Anti-Human HTR3C monoclonal antibodyHuman
GM-Tg-rg-MP0592-Ab-1/ GM-Tg-rg-MP0592-Ab-2Anti-Rat HTR3C monoclonal antibodyRat
GM-Tg-mg-MP0592-Ab-1/ GM-Tg-mg-MP0592-Ab-2Anti-Mouse HTR3C monoclonal antibodyMouse
GM-Tg-cynog-MP0592-Ab-1/ GM-Tg-cynog-MP0592-Ab-2Anti-Cynomolgus/ Rhesus macaque HTR3C monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0592-Ab-1/ GM-Tg-felg-MP0592-Ab-2Anti-Feline HTR3C monoclonal antibodyFeline
GM-Tg-cang-MP0592-Ab-1/ GM-Tg-cang-MP0592-Ab-2Anti-Canine HTR3C monoclonal antibodyCanine
GM-Tg-bovg-MP0592-Ab-1/ GM-Tg-bovg-MP0592-Ab-2Anti-Bovine HTR3C monoclonal antibodyBovine
GM-Tg-equg-MP0592-Ab-1/ GM-Tg-equg-MP0592-Ab-2Anti-Equine HTR3C monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0592-Ab-1/ GM-Tg-hg-MP0592-Ab-2; GM-Tg-rg-MP0592-Ab-1/ GM-Tg-rg-MP0592-Ab-2;
GM-Tg-mg-MP0592-Ab-1/ GM-Tg-mg-MP0592-Ab-2; GM-Tg-cynog-MP0592-Ab-1/ GM-Tg-cynog-MP0592-Ab-2;
GM-Tg-felg-MP0592-Ab-1/ GM-Tg-felg-MP0592-Ab-2; GM-Tg-cang-MP0592-Ab-1/ GM-Tg-cang-MP0592-Ab-2;
GM-Tg-bovg-MP0592-Ab-1/ GM-Tg-bovg-MP0592-Ab-2; GM-Tg-equg-MP0592-Ab-1/ GM-Tg-equg-MP0592-Ab-2
Products NameAnti-HTR3C monoclonal antibody
Formatmab
Target NameHTR3C
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-HTR3C benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species 5HT3C/ HTR3C VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0592
    Target NameHTR3C
    Gene ID170572,607416,101090040
    Gene Symbol and SynonymsHTR3C
    Uniprot AccessionQ8WXA8
    Uniprot Entry Name5HT3C_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000178084
    Target ClassificationN/A

    The target: HTR3C, gene name: HTR3C, also named as . The product of this gene belongs to the ligand-gated ion channel receptor superfamily. This gene encodes subunit C of the type 3 receptor for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. This receptor causes fast, depolarizing responses in neurons after activation. Genes encoding subunits C, D and E form a cluster on chromosome 3. .



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.